Molecular and cellular characterization of essential human genes.
Molecular and cellular characterization of essential human genes.
批准号:
10517781
负责人:
Mazhar Adli
金额:
$166.98万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-09-22 至 2027-06-30
中文摘要
我们建议生成条形码和条件空
英文摘要
We propose to generate barcoded and conditional null
alleles in a cellular system that can model early human development and a broad range of human
diseases. We will establish a data production research and development center in response to the
RFA-HG-21-029: Molecular Phenotypes of Null Alleles in Cells (MorPhiC) Phase 1, which aims to
establish a catalog of molecular and cellular phenotypes of null alleles for ultimately every human gene,
using in vitro multicellular systems. Our center will utilize a chemically inducible and reversible system
that enables the rapid depletion of target proteins. The approach permits temporal control of protein
levels to study the consequences of null alleles. We will utilize a super sensitive degron that rapidly
degrades the target protein of interest in response to a low dose of auxin, a cell membrane diffusible
small chemical plant hormone. We will combine CRISPR-based targeted locus engineering to
homozygous knock-in a mini auxin-inducible degron (mAID) at the end of the targe gene to create a
chemically controllable switch to create null-alleles in an open-access human induced pluripotent stem
(hiPSC) cell, which can be differentiated into various cell lineages and multicellular organoids to model
human development and diseases. Notably, each AID-degron will also contain gene-specific barcodes,
allowing tracking the fate of hundreds of thousands of null alleles when these engineered null alleles
are pooled.
The proposed approach is generalizable and can rapidly deplete target proteins codded by various
classes of human genes. Our strategy will be particularly advantageous and critical to study the null
phenotypes of essential genes, which cannot be studied by chronic depletion using genetic approaches
(such as CRISPR KO) because the knock-in results in cell death. Therefore, to highlight the utility of
our strategy, we prioritize creating null alleles by CRISPR mediated knock-in process to introduce
barcoded AID degron in 250 essential genes. We chose genes implicated in human diseases and subviable
phenotypes in the International Mouse Phenotyping Consortium (IMPC). We propose to catalog
the cellular phenotypes (survival, proliferation, mitotic function, and differentiation) and molecular
phonotypes, including gene expression and chromatin accessibility for select null alleles. This
information will provide unique insights into the biological function of these developmentally critical
genes. It will highlight the utility of establishing the chemically inducible degron system as a
generalizable strategy for the goals of the MorPhiC consortium. The created barcoded and conditional
null allele resource will provide a unique opportunity to temporally control the timing of null alleles in
pluripotent stem state and various terminally differentiated cell types or multicellular organoid systems
that can be generated from the pluripotent stem cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Chemo-mediated transcriptional reprogramming in ovarian cancer
-
批准号:10346704
-
项目类别:
-
资助金额:$47.23万
-
财政年份:2022
-
负责人:Mazhar Adli
-
依托单位:
Chemo-mediated transcriptional reprogramming in ovarian cancer
-
批准号:10709477
-
项目类别:
-
资助金额:$45.24万
-
财政年份:2022
-
负责人:Mazhar Adli
-
依托单位:
Molecular and cellular characterization of essential human genes.
-
批准号:10708906
-
项目类别:
-
资助金额:$163.13万
-
财政年份:2022
-
负责人:Mazhar Adli
-
依托单位:
Identifying the Drivers and Targeting Chemo Resistance in Ovarian Cancer
-
批准号:10166791
-
项目类别:
-
资助金额:$41.39万
-
财政年份:2017
-
负责人:Mazhar Adli
-
依托单位:
Identifying the Drivers and Targeting Chemo Resistance in Ovarian Cancer
-
批准号:9330488
-
项目类别:
-
资助金额:$42.92万
-
财政年份:2017
-
负责人:Mazhar Adli
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于MFSD2A调控血迷路屏障跨细胞囊泡转运机制的噪声性听力损失防治研究
-
批准号:82371144
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:汪雪玲
-
依托单位:
长寿基因SIRT7调控核苷酸切除修复通路的机制研究
-
批准号:32100605
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:耿安珂
-
依托单位:
溶酶体蛋白LAPTM4B通过与Xc-系统相互作用调控谷胱甘肽代谢的机制研究
-
批准号:32100623
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:周可成
-
依托单位:
小鼠肺分支早期发育中肺上皮单细胞的时-空转录组的建立与分析
-
批准号:32070795
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:蔡军
-
依托单位:
乳腺癌上皮间质转化中核苷酸代谢相关的功能蛋白发现和机理研究
-
批准号:32070748
-
项目类别:面上项目
-
资助金额:54.0万元
-
批准年份:2020
-
负责人:戴凌云
-
依托单位:
rhTβ4增强间充质干细胞调节T细胞代谢重塑治疗干眼的机制研究
-
批准号:32000530
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:陈小鸟
-
依托单位:
胰岛素和细菌信号协同调节巨噬细胞免疫反应的作用
-
批准号:92057105
-
项目类别:重大研究计划
-
资助金额:89.0万元
-
批准年份:2020
-
负责人:Tiffany Shy Yea Horng
-
依托单位:
一种全新的高尔基体胆固醇感应蛋白的鉴定和功能研究
-
批准号:32070755
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:钟辉
-
依托单位:
葡萄糖调节的AXIN溶酶体膜转运的分子机制
-
批准号:32070753
-
项目类别:面上项目
-
资助金额:59.0万元
-
批准年份:2020
-
负责人:李梦琪
-
依托单位:
胞浆甘氨酰-tRNA合成酶cytoGARS感知甘氨酸的分子机制及其对肝细胞癌的影响
-
批准号:32070756
-
项目类别:面上项目
-
资助金额:59.0万元
-
批准年份:2020
-
负责人:汪维
-
依托单位: